Search research articles
Contact Us
Filters
Showing results (71-80 of 93) with videos related to
Page
of 10
Sort By:
The Prostate
|
March 10, 2018
Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate-risk prostate cancer at high risk of distant recurrence and cancer-specific mortality
Jonathan Hayman, Ryan Phillips, Di Chen, et al.
Advances in Radiation Oncology
|
April 14, 2020
Online Prostate-Specific Membrane Antigen and Positron Emission Tomography-Guided Radiation Therapy for Oligometastatic Prostate Cancer
William T Hrinivich, Ryan Phillips, Angela J Da Silva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 9, 2022
Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease: A systematic review and individual patient data meta-analysis
Aisling S Barry, Joelle Helou, Andrea Bezjak, et al.
The Journal of Urology
|
November 9, 2022
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer
Jack R Andrews, Mohamed E Ahmed, Vidit Sharma, et al.
Epidemiology and Infection
|
November 30, 2023
An outbreak of <i>Salmonella Typhimurium</i> associated with the consumption of raw liver at an Eid al-Adha celebration in Wales (UK), July 2021
James P Adamson, Clare Sawyer, Gemma Hobson, et al.
Annals of Translational Medicine
|
July 21, 2025
Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy
Miguel Muniz, Daniel S Childs, Jack Andrews, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 17, 2019
Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience
Matthew P Deek, Colburn Yu, Ryan Phillips, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2024
Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics
Yufeng Cao, Philip Sutera, William Silva Mendes, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 17, 2020
Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer
Neil R Parikh, Eric M Chang, Nicholas G Nickols, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts
Jack R Andrews, Yohan Kim, Edlira Horjeti, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 93) with videos related to
Sort By:
Page
of 10
The Prostate
|
March 10, 2018
Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate-risk prostate cancer at high risk of distant recurrence and cancer-specific mortality
Jonathan Hayman, Ryan Phillips, Di Chen, et al.
Advances in Radiation Oncology
|
April 14, 2020
Online Prostate-Specific Membrane Antigen and Positron Emission Tomography-Guided Radiation Therapy for Oligometastatic Prostate Cancer
William T Hrinivich, Ryan Phillips, Angela J Da Silva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 9, 2022
Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease: A systematic review and individual patient data meta-analysis
Aisling S Barry, Joelle Helou, Andrea Bezjak, et al.
The Journal of Urology
|
November 9, 2022
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer
Jack R Andrews, Mohamed E Ahmed, Vidit Sharma, et al.
Epidemiology and Infection
|
November 30, 2023
An outbreak of <i>Salmonella Typhimurium</i> associated with the consumption of raw liver at an Eid al-Adha celebration in Wales (UK), July 2021
James P Adamson, Clare Sawyer, Gemma Hobson, et al.
Annals of Translational Medicine
|
July 21, 2025
Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy
Miguel Muniz, Daniel S Childs, Jack Andrews, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 17, 2019
Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience
Matthew P Deek, Colburn Yu, Ryan Phillips, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2024
Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics
Yufeng Cao, Philip Sutera, William Silva Mendes, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 17, 2020
Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer
Neil R Parikh, Eric M Chang, Nicholas G Nickols, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts
Jack R Andrews, Yohan Kim, Edlira Horjeti, et al.
Page
of 10